KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Bionano Genomics (BNGO) Shares Outstanding (Weighted Average) (2017 - 2025)

Historic Shares Outstanding (Weighted Average) for Bionano Genomics (BNGO) over the last 9 years, with Q3 2025 value amounting to $5.3 million.

  • Bionano Genomics' Shares Outstanding (Weighted Average) rose 27302.59% to $5.3 million in Q3 2025 from the same period last year, while for Sep 2025 it was $5.3 million, marking a year-over-year increase of 27302.59%. This contributed to the annual value of $1.3 million for FY2024, which is 12337.43% up from last year.
  • According to the latest figures from Q3 2025, Bionano Genomics' Shares Outstanding (Weighted Average) is $5.3 million, which was up 27302.59% from $3.4 million recorded in Q2 2025.
  • In the past 5 years, Bionano Genomics' Shares Outstanding (Weighted Average) registered a high of $284.6 million during Q1 2022, and its lowest value of $569000.0 during Q4 2023.
  • In the last 5 years, Bionano Genomics' Shares Outstanding (Weighted Average) had a median value of $28.9 million in 2022 and averaged $83.4 million.
  • Its Shares Outstanding (Weighted Average) has fluctuated over the past 5 years, first skyrocketed by 64204.79% in 2021, then plummeted by 9803.26% in 2023.
  • Bionano Genomics' Shares Outstanding (Weighted Average) (Quarter) stood at $276.8 million in 2021, then crashed by 89.55% to $28.9 million in 2022, then tumbled by 98.03% to $569000.0 in 2023, then surged by 123.37% to $1.3 million in 2024, then skyrocketed by 319.98% to $5.3 million in 2025.
  • Its Shares Outstanding (Weighted Average) was $5.3 million in Q3 2025, compared to $3.4 million in Q2 2025 and $2.7 million in Q1 2025.